what are the most common glp 1 drugs List of GLP-1 Receptor Agonists for Diabetes & Weight Loss How GLP-1 medications are transforming

What GLP-1 drugs are available

Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial

As is generally true for the complex biochemistry of our bodies, too much of any one thing can turn detrimental

Additionally, it has been suggested that GIPR agonists and antagonists might target different CNS receptor populations, with evidence showing that acylated peptide GIPR agonists act on GABAergic neurons to further reduce food intake and body weight when combined with GLP-1R agonists in mice 39,40

Current developments and ongoing studies As indicated above, several studies are ongoing that aim to increase our understanding of the kidney effects of GLP-1 receptor agonists and the newer incretin mimetics (Table 1)

Notably, the SOS study showed that in people with T2D, achieving and maintaining 15% WL over 15 years was associated with reductions in both micro- and macrovascular complications following BS [54]